Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction
 
  • Details
Options

Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction

Journal
Atherosclerosis
Date Issued
2007-11-01
Author(s)
TING-HSING CHAO  
DOI
10.1016/j.atherosclerosis.2006.11.001
URI
https://www.scopus.com/pages/publications/35248897117
https://scholars.csmu.edu.tw/handle/123456789/32328
Abstract
Objectives: Cytochrome P450 (CYP) 2J2 is expressed in vascular endothelium and metabolizes arachidonic acid to biologically active epoxyeicosatrienoic acids (EETs), which are potent endogenous vasodilators and inhibitors of vascular inflammation. We aimed to elucidate the relationship between the functional CYP2J2*7 polymorphism and smoking for the onset of premature myocardial infarction (MI). Patients/methods: We studied 200 patients with acute MI onset under 45 years (84% men) and 200 sex- and age-matched controls. The polymorphism was determined using PCR and direct DNA sequencing analysis. Results: The CYP2J2*7 GT + TT genotype was significantly more prevalent in premature MI patients (32.0% versus 22.0%; p = 0.02). Multiple logistic regression analysis showed four independent risk factors: the CYP2J2*7 T allele (OR 1.78, 95% confidence interval [CI] 1.1-6.4; p = 0.02), smoking (OR 3.05, 95% CI 1.6-7.3; p < 0.01), diabetes mellitus (OR 3.24, 95% CI 1.2-6.6; p < 0.01), and hypertension (OR 1.95, 95% CI 1.1-5.7; p < 0.01). Among non-smoking patients, the CYP2J2*7 T allele was associated with a 1.3-fold risk. However, smoking T-allele carriers had a significantly 6.7-fold higher risk (p = 0.01 for interaction). This variant, but not wild type, significantly reduced promoter activity with nicotine in vitro. EET metabolites were significantly lower among CYP2J2*7 T allele carriers than the GG subjects (p < 0.05). Smoking could further lower EET concentrations in T allele carriers than the non-smokers, especially in MI patients (3.3 ± 1.0 ng/mL versus 6.8 ± 1.3 ng/mL; p = 0.001). Conclusions: The CYP2J2*7 polymorphism and premature MI were synergistically and significantly associated in Taiwanese patients.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback